| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/14/2013 | US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040942 Salts of potassium atp channel openers and uses thereof |
| 02/14/2013 | US20130040905 Combination Of Drugs With Protein-Binding Prodrugs |
| 02/14/2013 | US20130040883 Stable growth hormone compounds |
| 02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039857 Methods of suppressing cancer, increasing weight loss and/or increasing insulin sensitivity |
| 02/14/2013 | CA2844580A1 Stem cell therapy using inhibitors of lysophosphatidic acid |
| 02/14/2013 | CA2844282A1 Composition for controlled ovarian stimulation |
| 02/13/2013 | EP2556082A2 Substituted androst-4-ene diones |
| 02/13/2013 | EP2555618A1 Methods of using diacerein as an adjunctive therapy for diabetes |
| 02/13/2013 | CN102933218A Posology and administration of glucocorticoid based compositions |
| 02/13/2013 | CN102924587A Long-acting salmon calcitonin analog, and preparation method and use thereof |
| 02/13/2013 | CN102924430A Desloratadine derivatives, and preparation method and application thereof |
| 02/13/2013 | CN102924363A Crystal forms of saxagliptin and processes for preparing same |
| 02/13/2013 | CN102920695A Benzofuran endothelin receptor antagonist and use |
| 02/13/2013 | CN101569687B Herbal medicine for osteoporosis and related conditions |
| 02/12/2013 | US8372804 Delivery of active agents |
| 02/12/2013 | CA2566873C Use of drug combinations for treating insulin resistance |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018675A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | WO2013017374A1 Anti -inflammatory steroids condensed in position 16,17 with pyrrolidine ring |
| 02/07/2013 | WO2013016807A1 Insulin secretion promoting agents |
| 02/07/2013 | WO2012123482A3 Isoxazolidine derivatives |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/07/2013 | US20130034492 Class I Anti-CEA Antibodies and Uses Thereof |
| 02/07/2013 | CA2843782A1 Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring |
| 02/07/2013 | CA2843238A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | CA2842450A1 Insulin secretion promoting agents |
| 02/06/2013 | CN102911266A Novel salmon calcitonin analogue and preparation method as well as use thereof |
| 02/06/2013 | CN102908621A New application of miRNAs for regulating insulin sensitivity as target |
| 02/06/2013 | CN102908504A Chinese medicinal composition for regulating female endocrine dyscrasia |
| 02/06/2013 | CN102908501A Traditional Chinese medicine composition for treating hyperthyroidism and preparation method and use method thereof |
| 02/06/2013 | CN102908433A Preparation method of medicament for treating hypothyroidism |
| 02/06/2013 | CN102908332A Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102603627B Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
| 02/06/2013 | CN101166736B Polymorph form II of tanaproget |
| 02/05/2013 | CA2518903C Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 01/31/2013 | WO2013016725A1 Progesterone antagonists |
| 01/31/2013 | WO2013014627A1 Pyrazoline derivatives and their use as selective androgen receptor modulators |
| 01/31/2013 | WO2013013273A1 Modulators of protease activated receptors |
| 01/31/2013 | WO2012123493A9 Isoxazolidine derivatives |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028968 Compositions and methods to relieve chronic diseases symptoms |
| 01/31/2013 | US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| 01/31/2013 | CA2846573A1 Progesterone antagonists |
| 01/31/2013 | CA2842566A1 Pyrazoline derivatives and their use as selective androgen receptor modulators |
| 01/30/2013 | EP2551262A1 Glutamate derivatives or salts thereof |
| 01/30/2013 | EP2550288A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 01/30/2013 | CN102906103A Compositions and methods for non-toxic delivery of antiprogestins |
| 01/30/2013 | CN102895611A Prescription of traditional Chinese medicine used for treating hypothyroidism caused by spleen-kidney yang deficiency |
| 01/30/2013 | CN102895497A Preparation technology and production method for integrated new formulation of lily and radix rehmanniae decoction |
| 01/30/2013 | CN102895407A Chinese herbal medicine composition for treating hyperthyroidism and method for preparing Chinese herbal medicine composition for treating hyperthyroidism |
| 01/30/2013 | CN102895342A Medicinal composition for preventing or/and treating diabetes mellitus and application of medicinal composition |
| 01/30/2013 | CN102895323A Method for extracting buckwheat flavonoid |
| 01/30/2013 | CN102895290A Preparation technology and production method for integrated new formulation of snakegourd root and oyster powder |
| 01/30/2013 | CN102895237A Application of Gypensapogenin A in drugs for resisting osteoporosis caused by estrogen deficiency |
| 01/30/2013 | CN102895211A Sudden death and hypertension resistant metoprolol intelligent medicine release system and its preparation method |
| 01/30/2013 | CN102366621B Plant estrogenic effect of acanthopanax biochemical traditional Chinese medicine compound extract and its application |
| 01/30/2013 | CN102191160B Method for brewing estrogen health wine by using natural plant |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | CA2454050C Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 01/24/2013 | WO2013012644A1 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs |
| 01/24/2013 | WO2013011431A1 A topical composition for the treatment of alopecia |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023477 Growth hormone fusion proteins |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130022674 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 01/23/2013 | EP2547650A1 Agomelatine hydrobromide hydrate and preparation thereof |
| 01/23/2013 | EP2158900B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/23/2013 | CN102892757A Phenol derivatives and the pharmaceutical or cosmetic use thereof |
| 01/23/2013 | CN102892749A Agomelatine hydrobromide hydrate and preparation thereof |
| 01/23/2013 | CN102885792A Oral solid rapid release preparation of cinacalcet hydrochloride |
| 01/23/2013 | CN102885782A Growth hormone-containing nanometer medicament microspheres and preparation method thereof |
| 01/23/2013 | CN102049012B Traditional Chinese medicine composition for treating sexual precocity of children and preparation and quality detection method thereof |
| 01/23/2013 | CN101888830B 透皮递送系统 Transdermal delivery systems |
| 01/23/2013 | CN101745114B Method for preparing glucose-sensitive insulin controlled-release biological material |
| 01/22/2013 | CA2683522C 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/17/2013 | WO2013008202A1 Treatment of excessive menstrual bleeding associated with uterine fibroids |
| 01/17/2013 | WO2013007167A1 Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018027 Compositions and methods for non-toxic delivery of antiprogestins |
| 01/17/2013 | US20130018012 Lipid composition for improving brain function |
| 01/17/2013 | US20130017994 Methods of Treating Glucose Metabolism Disorders |
| 01/17/2013 | US20130017950 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017208 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 01/17/2013 | US20130017172 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 01/17/2013 | CA2836346A1 Treatment of excessive menstrual bleeding associated with uterine fibroids |
| 01/16/2013 | EP2546231A1 Alkylamine derivative |
| 01/16/2013 | EP2545922A1 Treatment of excessive menstrual bleeding associated with uterine fibroids |